MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 18 filers reported holding MEDICINES CO in Q1 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $741,000 | +92.5% | 8,730 | +13.3% | 0.00% | 0.0% |
| Q3 2019 | $385,000 | -5.4% | 7,705 | -26.6% | 0.00% | 0.0% |
| Q2 2017 | $407,000 | +24.5% | 10,495 | +56.7% | 0.00% | 0.0% |
| Q1 2017 | $327,000 | -64.1% | 6,697 | -75.0% | 0.00% | -50.0% |
| Q4 2016 | $910,000 | +54.8% | 26,749 | +73.6% | 0.00% | +100.0% |
| Q3 2016 | $588,000 | +126.2% | 15,405 | +125.2% | 0.00% | 0.0% |
| Q3 2015 | $260,000 | -30.3% | 6,842 | -47.4% | 0.00% | 0.0% |
| Q2 2015 | $373,000 | +31.8% | 13,009 | +29.6% | 0.00% | 0.0% |
| Q1 2015 | $283,000 | +2.2% | 10,034 | +0.8% | 0.00% | 0.0% |
| Q4 2014 | $277,000 | +28.8% | 9,959 | +42.3% | 0.00% | 0.0% |
| Q2 2013 | $215,000 | -8.1% | 7,000 | 0.0% | 0.00% | 0.0% |
| Q1 2013 | $234,000 | -39.5% | 7,000 | -53.3% | 0.00% | -50.0% |
| Q3 2012 | $387,000 | -20.0% | 15,000 | -28.9% | 0.00% | 0.0% |
| Q2 2012 | $484,000 | – | 21,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
| Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
| Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
| BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
| Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
| CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
| DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
| Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
| Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
| Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |